Alveo (Diagnostic Equipment)

Alameda, CA · Founded 2014 · Privately Held (backing)

Developer of diagnostics technology designed to address global challenges and opportunities surrounding infectious diseases. Alveo (Diagnostic Equipment) is based in Alameda, CA and was founded in 2014. Its last reported valuation was $116 million in Mar 2021. It has raised $83.6 million.

Last reported valuation
$116.0M
Oct 2026
Priced at
—
Total raised
$83.6M
Last round
—

Alveo (Diagnostic Equipment) key facts

as of Oct 2026
  • Developer of diagnostics technology designed to address global challenges and opportunities surrounding infectious diseases.
  • Alveo (Diagnostic Equipment) is valued at approximately $116.0M as of Oct 2026 (last reported valuation).
  • It has raised $83.6M; the latest was Later Stage VC in Jun 2025.
  • Notable investors include Gates Foundation, Celesta Capital, Black Diamond Ventures, Seed-Resolute, Opaleye — 14 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$116.0M

Alveo (Diagnostic Equipment)'s last reported valuation, Mar 2021. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Alveo (Diagnostic Equipment) with a free account
  • ·The complete investor list: 14 names
  • ·Watch Alveo (Diagnostic Equipment): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Alveo (Diagnostic Equipment) funding rounds

No rounds on record

No funding rounds for Alveo (Diagnostic Equipment) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Alveo (Diagnostic Equipment) valuation

Alveo (Diagnostic Equipment)'s last reported valuation was $116 million in Mar 2021. No priced round, secondary trade or fund mark has surfaced since.

Alveo (Diagnostic Equipment) investors

14 investors are on record for Alveo (Diagnostic Equipment), including Gates Foundation, Celesta Capital, Black Diamond Ventures and Seed-Resolute.

About Alveo (Diagnostic Equipment)

Developer of diagnostics technology designed to address global challenges and opportunities surrounding infectious diseases. The company's cloud-strengthened technology helps in the creation of vast datasets in order to track global infectious disease outbreaks and connect individuals with treatments, enabling consumers, healthcare professionals, and treatment providers with the ability to detect a range of diseases that threaten public health.

Sector
Healthcare
HQ
Alameda, CA, United States
Founded
2014
Employees
67
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.